BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rafiq A, Tariq H, Abbas N, Shenoy R. Atypical hemolytic-uremic syndrome: a case report and literature review. Am J Case Rep 2015;16:109-14. [PMID: 25708146 DOI: 10.12659/AJCR.892907] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mota S, Filipe C, Almeida AL. Atypical hemolytic uremic syndrome: An unusual postoperative complication. Rev Esp Anestesiol Reanim (Engl Ed) 2018;65:351-5. [PMID: 29426622 DOI: 10.1016/j.redar.2017.12.014] [Reference Citation Analysis]
2 Matsumura D, Tanaka A, Nakamura T, Sato E, Node K. Coexistence of atypical hemolytic uremic syndrome and crescentic IgA nephropathy treated with eculizumab: a case report. Clin Nephrol Case Stud 2016;4:24-8. [PMID: 29043138 DOI: 10.5414/CNCS108889] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Costin M, Cinteza E, Balgradean M. Hemolytic Uremic Syndrome - Case report. Maedica (Bucur) 2019;14:298-300. [PMID: 31798749 DOI: 10.26574/maedica.2019.14.3.298] [Reference Citation Analysis]
4 Nanjappa S, Singh V, Uttamchandani S, Pabbathi S. Thrombotic Microangiopathy in a Patient Treated With Gemcitabine. Cancer Control 2017;24:54-6. [PMID: 28178713 DOI: 10.1177/107327481702400108] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Wada H, Matsumoto T, Suzuki K, Imai H, Katayama N, Iba T, Matsumoto M. Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy. Thromb J 2018;16:14. [PMID: 30008620 DOI: 10.1186/s12959-018-0168-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 9.5] [Reference Citation Analysis]
6 Palma LM, Langman CB. Critical appraisal of eculizumab for atypical hemolytic uremic syndrome. J Blood Med 2016;7:39-72. [PMID: 27110144 DOI: 10.2147/JBM.S36249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
7 Chen M, Zhuang J, Yang J, Wang D, Yang Q. Atypical hemolytic uremic syndrome induced by CblC subtype of methylmalonic academia: A case report and literature review. Medicine (Baltimore) 2017;96:e8284. [PMID: 29068997 DOI: 10.1097/MD.0000000000008284] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Quiroga B, de Lorenzo A, Vega C, de Alvaro F. A Case Report and Literature Review of Eculizumab Withdrawal in Atypical Hemolytic-Uremic Syndrome. Am J Case Rep 2016;17:950-6. [PMID: 27974740 DOI: 10.12659/ajcr.899764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Khattab A, Yellala A, Mamadgi J, Patruni S, Kaplan R. Aggressive Disease and Rare Sequelae in a Unique Case of Atypical Hemolytic Uremic Syndrome Secondary to Adult Onset Still's Disease. J Hematol 2019;8:64-7. [PMID: 32300446 DOI: 10.14740/jh491] [Reference Citation Analysis]
10 Asif A, Nayer A, Haas CS. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab. J Nephrol 2017;30:347-62. [PMID: 27848226 DOI: 10.1007/s40620-016-0357-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]